Patients gather to praise
minimally
invasive technique used in treating tumors By MICHELLE BRANDT
When Jeanie
Schmidt, a critical care nurse from Foster City,
lost hearing in her left ear and experienced
numbing in her face, she prayed that her first
instincts were off. I said to the doctor,
`I think I have an acoustic neuroma (a brain
tumor), but I'm hoping I'm wrong. Tell me it's
wax, tell me it's anything,' Schmidt
recalled.
It wasn't wax,
however, and Schmidt who wound up in the
Stanford Hospital emergency room when her
symptoms worsened was quickly forced to
make a decision regarding treatment for her
tumor.
On July 13,
Schmidt found herself back at Stanford but
this time with a group of patients who were
treated with the same minimally invasive
treatment that Schmidt ultimately chose: the
CyberKnife. She was one of 40 former patients who
met with Stanford faculty and staff to discuss
their experiences with the CyberKnife a
radiosurgery system designed at Stanford by John
Adler Jr., MD, in 1994 for performing
neurosurgeries without incisions.
I wanted
the chance to thank everyone again and to share
experiences with other patients, said
Schmidt, who had the procedure on June 20 and
will have an MRI in six months to determine its
effectiveness. I feel really lucky that I
came along when this technology was around.
The CyberKnife
is the newest member of the radiosurgery family.
Like its ancestor, the 33-year-old Gamma Knife,
the CyberKnife uses 3-D computer targeting to
deliver a single, large dose of radiation to the
tumor in an outpatient setting. But unlike the
Gamma Knife which requires patients to
wear an external frame to keep their head
completely immobile during the procedure
the CyberKnife can make real-time adjustments to
body movements so that patients aren't required
to wear the bulky, uncomfortable head gear.
The procedure
provides patients an alternative to both
difficult, risky surgery and conventional
radiation therapy, in which small doses of
radiation are delivered each day to a large area.
The procedure is used to treat a variety of
conditions including several that can't be
treated by any other procedure but is most
commonly used for metastases (the most common
type of brain tumor in adults), meningomas
(tumors that develop from the membranes that
cover the brain), and acoustic neuromas. Since
January 1999, more than 335 patients have been
treated at Stanford with the CyberKnife.
The July 13
meeting began with a presentation by Adler, who
provided an historical oversight of radiosurgery
and expressed gratitude to the patients who chose
to undergo the procedure. I feel very proud
of what I've done, but how can I not appreciate
the courage of these patients? said Adler,
professor of neurosurgery and director of
radiosurgery and stereotactic surgery at
Stanford. Because of them, patients all
over the world are having their surgeries done
differently.
Patients also
took turns at the podium. Valerie DeGrendele
described the years of pain she endured. From the
age of 13, DeGrendele experienced frequent
episodes of feeling like someone was
repeatedly stabbing me in the neck,
followed by paralysis of her right side. Doctors
couldn't determine what was wrong with her, and
the family chiropractor told her parents that she
would be paralyzed for the rest of her life.
Other doctors said there was nothing they could
do for her. It wasn't until years later, when she
was diagnosed as having an arteriovenous
malformation dangerous masses of abnormal
blood vessels on her spinal cord that she
was referred to Adler.
It was the
first time in my life that anyone offered me
hope, DeGrendele said. She had the
procedure (I was in and out of there faster
than it takes to go grocery shopping, she
noted) and the malformation has since shrunk by
75 percent.
Donald Sabin, a
former patient who emceed the event, announced
the formation of a patient support group that
will not only serve as a resource for CyberKnife
patients but will also educate others about the
procedure. We need to take an oath as
patients to get the message across that a
minimally invasive treatment is available,
he said.
|